Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment Using ORA | ASCRS
Presentation
Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment Using ORA
May 2020
Meeting: 2020 Virtual Annual Meeting
Session: SPS-102 Toric IOLs - Astigmatism
Author: P. Dee G. Stephenson, MD, ABO
This content is only available for ASCRS Members

This content from the 2020 ASCRS Virtual Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

Purpose
To assess early clinical experience with new spherical aberration neutral, hydrophobic acrylic toric monofocal intraocular lens (MX60ET IOL, Bausch and Lomb, Inc.) with enhanced material properties to accelerate optic recovery.

Methods
Prospective, single-surgeon, consecutive case series in which novel toric IOLs were implanted and intraoperative aberrometry was used to confirm IOL power and axis alignment. All patients were assessed for uncorrected visual acuities (UCVAs) at distance and intermediate and near, MRSE and absolute prediction error (APE) were collected. Surgical technique with new toric IOL will be shared at the conference. 

Results
Initial outcomes showed improved surgical efficiency with enhanced toric (MX60ET) IOL. Enhanced time for haptics to engage capsular and quicker toric alignment with intraocular aberrometry. Additional clinical endpoints are currently being collected and will be presented at the conference.

Conclusion
Initial outcomes show improved surgical efficiency with new enhanced toric IOL as compared to the previous non-enhanced version.
View More Presentations from this Session

This presentation is from the session "SPS-102 Toric IOLs - Astigmatism" from the 2020 ASCRS Virtual Annual Meeting held on May 16-17, 2020.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.